As of September 2023 iRadimed has a market cap of $0.55 Billion. This makes iRadimed the world's 5588th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2023 | $0.55 B | 57.29% |
2022 | $0.35 B | -38.67% |
2021 | $0.57 B | 106.55% |
2020 | $0.28 B | 2.02% |
2019 | $0.27 B | 2.34% |
2018 | $0.26 B | 68.09% |
2017 | $0.15 B | 34.49% |
2016 | $0.11 B | -62.04% |
2015 | $0.31 B | 124.53% |
2014 | $0.13 B |
On Sep 29th, 2023 the market cap of iRadimed was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
![]() Edwards Lifesciences EW | $42.11 B | 7,431.79% | ๐บ๐ธ USA |
![]() NuVasive NUVA | $2.08 B | 272.84% | ๐บ๐ธ USA |
![]() DexCom DXCM | $9.06 B | 1,521.79% | ๐บ๐ธ USA |
![]() AtriCure ATRC | $2.07 B | 270.89% | ๐บ๐ธ USA |